Alternative diagnosis for many referred for optic neuritis

December 8, 2017

(HealthDay)—Almost 60 percent of patients referred for acute optic neuritis have an alternative diagnosis, according to a study published online Dec. 7 in JAMA Ophthalmology.

Leanne Stunkel, M.D., from the Washington University School of Medicine in St. Louis, and colleagues conducted a retrospective clinic-based cross-sectional study of new patient encounters to examine the incidence of and characterize factors contributing to overdiagnosis of acute optic neuritis. Data were included for 122 patients referred for acute optic neuritis at a neuro-ophthalmology clinic. Definite diagnosis was determined by neuro-ophthalmologists; the Diagnosis Error Evaluation and Research taxonomy tool was applied to categorize diagnostic errors for patients with alternative diagnoses.

The researchers found that 40.2 percent of the patients were confirmed to have optic neuritis and 59.8 percent had an alternative . Headache and eye pain, functional visual loss, and other optic neuropathies were the most common alternative diagnoses. Eliciting or interpreting critical elements of history was the most common diagnostic error, which occurred in 33 percent of with alternative diagnoses. Errors weighing or considering alternative diagnoses, errors weighing or interpreting physical examination findings, and misinterpreting diagnostic test results were also common errors (32, 21, and 15 percent, respectively).

"Understanding pitfalls leading to overdiagnosis of optic neuritis may improve clinicians' diagnostic process," the authors write.

Explore further: Team develops neuro test that distinguishes demyelinating diseases from multiple sclerosis

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Team develops neuro test that distinguishes demyelinating diseases from multiple sclerosis

November 28, 2017
Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease (IDD) but may be unsure of the exact disorder. Neurologic-related ...

Anti-cell death agent a potential treatment for vision loss associated with multiple sclerosis

February 9, 2017
A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study by researchers in the Perelman School ...

Mayo Clinic researchers demonstrate value of second opinions

April 4, 2017
Many patients come to Mayo Clinic for a second opinion or diagnosis confirmation before treatment for a complex condition. In a new study, Mayo Clinic reports that as many as 88 percent of those patients go home with a new ...

RT dose main risk for radiation-induced optic neuropathy

February 13, 2017
(HealthDay)—The main risk factor for developing radiation-induced optic neuropathy (RION) is radiation dose, with no indication of other significant risk factors, according to a study published online Feb. 9 in Clinical ...

AAN: phenytoin neuroprotective in optic neuritis

April 17, 2015
(HealthDay)—Phenytoin appears to be neuroprotective in acute optic neuritis (AON), according to a study scheduled to be presented at the annual meeting of the American Academy of Neurology, held from April 18 to 25 in Washington, ...

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.